Gastroprotective effects of Erythrina speciosa (Fabaceae) leaves cultivated in Egypt against ethanol-induced gastric ulcer in rats.
Animals
Anti-Ulcer Agents
/ pharmacology
Cyclooxygenase 2
/ metabolism
Egypt
Ethanol
Fabaceae
Gastric Mucosa
/ drug effects
Helicobacter pylori
/ drug effects
Male
Mucins
/ metabolism
NF-kappa B
/ metabolism
Nitric Oxide Synthase Type II
/ metabolism
Oxidative Stress
/ drug effects
Plant Extracts
/ pharmacology
Plant Leaves
Rats, Sprague-Dawley
Stomach Ulcer
/ chemically induced
Anti-inflammatory
Erythrina
Gastroprotective
Helicobacter pylori
LC-MS
Ulcer
Journal
Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310
Informations de publication
Date de publication:
10 Feb 2020
10 Feb 2020
Historique:
received:
26
06
2019
revised:
07
10
2019
accepted:
09
10
2019
pubmed:
14
10
2019
medline:
6
5
2020
entrez:
14
10
2019
Statut:
ppublish
Résumé
Members of the genus Erythrina have been traditionally used in the treatment of various ailments such as inflammation and gastrointestinal disorders. Erythrina speciosa (Fabaceae) is a spiny, deciduous shrub or small tree native to Southern America in Brazil. It is cultivated in Africa and Asia. The traditional usage of E. speciosa indicated its antibacterial, analgesic, and anti-inflammatory activities. Evaluation of the phytochemical constituents, gastroprotective effects and possible mechanism of action of the ethyl acetate fraction obtained from the methanol extract of E. speciosa leaves (ESLE). Chemical characterization of ESLE was done using high performance liquid chromatography coupled to mass spectrometry (HPLC-MS). The gastroprotective activity of ESLE was evaluated using ethanol-induced gastric-ulcer model in rats. Rats were pre-treated with ESLE 25, 50 and 100 mg/kg 1 h before the administration of absolute ethanol. Histological analysis, mucin content, and total acidity were evaluated. The possible mechanism of action of ESLE was studied through the examination of oxidative stress and inflammatory markers, PGE2, and NF-κB, iNOS, COX-2, and HSP-70 immunoexpression. In vitro, anti-Helicobacter pylori activity of ESLE was also studied using micro-well dilution method. Fourteen compounds were tentatively identified including alkaloids, flavonoids, and saponins. ESLE exerted a powerful gastroprotective effect. The pre-treatment with ESLE at different doses resulted in a significant reduction in gastric lesions and significant elevation in the mucin production. These effects could be partially mediated by the potent anti-inflammatory activity of ESLE as evidenced by the significant reduction in the immunoexpression of NF-κB, COX-2, iNOS and the reduction in the pro-inflammatory marker, TNF-α. ESLE counteracted the ethanol-induced oxidative stress by increasing the levels of depleted GSH and catalase as well as significantly attenuating the ethanol-induced lipid peroxidation tissue levels. In addition, ESLE exhibited in vitro antibacterial activity against H. pylori. The chemical constituents of ESLE strongly support its potent gastroprotective effect suggesting its future potential application in the management of gastric ulcer by eliminating its symptoms and causes including H. pylori.
Identifiants
pubmed: 31606535
pii: S0378-8741(19)32565-6
doi: 10.1016/j.jep.2019.112297
pii:
doi:
Substances chimiques
Anti-Ulcer Agents
0
Mucins
0
NF-kappa B
0
Plant Extracts
0
Ethanol
3K9958V90M
Nitric Oxide Synthase Type II
EC 1.14.13.39
Nos2 protein, rat
EC 1.14.13.39
Cyclooxygenase 2
EC 1.14.99.1
Ptgs2 protein, rat
EC 1.14.99.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112297Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.